Suchergebnisse - "90Y-pentixather"

PubPharm (7)

1

CXCR4-targeted theranostics in oncology

enthalten in: European journal of nuclear medicine and molecular imaging | 2022

von Buck, A. | Serfling, S. | Lindner, T. | +6

2

Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [68Ga]Ga-PentixaFor PET/CT

enthalten in: Molecular imaging and biology | 2022

von Serfling, S. | Lapa, C. | Dreher, N. | +9

3

A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency

enthalten in: Theranostics | 2020

von Osl, T. | Schmidt, A. | Schwaiger, M. | +2

4

Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2019

von Maurer, S. | Herhaus, P. | Lippenmeyer, R. | +10

5

Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy

enthalten in: British journal of haematology | 2019

von Lapa, C. | Lückerath, K. | Kircher, S. | +10

6

Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients

enthalten in: Clinical nuclear medicine | 2017

von Bluemel, C. | Hahner, S. | Heinze, B. | +9

7

First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2016

von Herrmann, K. | Schottelius, M. | Lapa, C. | +16

1
[1]